Dataset: Absence of significant overlap in transcriptional patterns between operationally tolerant liver and kidney recipients
Transplant recipients spontaneously accepting their grafts in the absence of immunosuppression demonstrate the feasibility of attaining...
Transplant recipients spontaneously accepting their grafts in the absence of immunosuppression demonstrate the feasibility of attaining allograft tolerance in humans. Previous studies have identified blood transcriptional and cell phenotypic markers specific for either liver or kidney tolerant recipients, but the two settings have not been directly compared yet employing the same platforms. To identify potential similarities in immune parameters between recipients tolerant to different organs, we analyzed blood samples from tolerant and non-tolerant liver and kidney recipients employing whole genome expression microarrays. Tolerant and non-tolerant liver and kidney recipients differed in their peripheral blood expression patterns, but no significant overlap was observed between the two datasets. This was confirmed at the functional level by employing gene set enrichment analysis.The lack of obvious similarities in immune parameters associated with liver and kidney tolerant recipients implies the involvement of different mechanisms in the two settings and argues against the existence of a common immunological constant of spontaneous operational tolerance in clinical transplantation. The complete database comprised the expression measurements of 54,675 genes for liver and kidney trasplant inmunotolerance groups (n=12 for each group).A group of 12 samples from Healthy volunteer are included.
- Species:
- human
- Samples:
- 72
- Source:
- E-GEOD-22707
- Updated:
- Dec.12, 2014
- Registered:
- Sep.15, 2014
Sample | IMMUNOTOLERANCE GROUP | OUTCOME |
---|---|---|
GSM562612 | L-Tol | Liver recipients maintaining stable graft function in the absence of immunosuppressive therapy |
GSM562612 | L-Tol | Liver recipients maintaining stable graft function in the absence of immunosuppressive therapy |
GSM562612 | L-Tol | Liver recipients maintaining stable graft function in the absence of immunosuppressive therapy |
GSM562612 | L-Tol | Liver recipients maintaining stable graft function in the absence of immunosuppressive therapy |
GSM562612 | L-Tol | Liver recipients maintaining stable graft function in the absence of immunosuppressive therapy |
GSM562612 | L-Tol | Liver recipients maintaining stable graft function in the absence of immunosuppressive therapy |
GSM562612 | L-Tol | Liver recipients maintaining stable graft function in the absence of immunosuppressive therapy |
GSM562612 | L-Tol | Liver recipients maintaining stable graft function in the absence of immunosuppressive therapy |
GSM562612 | L-Tol | Liver recipients maintaining stable graft function in the absence of immunosuppressive therapy |
GSM562612 | L-Tol | Liver recipients maintaining stable graft function in the absence of immunosuppressive therapy |
GSM562612 | L-Tol | Liver recipients maintaining stable graft function in the absence of immunosuppressive therapy |
GSM562612 | L-Tol | Liver recipients maintaining stable graft function in the absence of immunosuppressive therapy |
GSM562624 | K-Tol | Kidney recipients with stable long-term graft function in the absence of immunosuppressive therapy |
GSM562624 | K-Tol | Kidney recipients with stable long-term graft function in the absence of immunosuppressive therapy |
GSM562624 | K-Tol | Kidney recipients with stable long-term graft function in the absence of immunosuppressive therapy |
GSM562624 | K-Tol | Kidney recipients with stable long-term graft function in the absence of immunosuppressive therapy |
GSM562624 | K-Tol | Kidney recipients with stable long-term graft function in the absence of immunosuppressive therapy |
GSM562624 | K-Tol | Kidney recipients with stable long-term graft function in the absence of immunosuppressive therapy |
GSM562624 | K-Tol | Kidney recipients with stable long-term graft function in the absence of immunosuppressive therapy |
GSM562624 | K-Tol | Kidney recipients with stable long-term graft function in the absence of immunosuppressive therapy |
GSM562624 | K-Tol | Kidney recipients with stable long-term graft function in the absence of immunosuppressive therapy |
GSM562624 | K-Tol | Kidney recipients with stable long-term graft function in the absence of immunosuppressive therapy |
GSM562624 | K-Tol | Kidney recipients with stable long-term graft function in the absence of immunosuppressive therapy |
GSM562624 | K-Tol | Kidney recipients with stable long-term graft function in the absence of immunosuppressive therapy |
GSM562636 | L-NonTol | Liver recipients in whom drug weaning was attempted but this led to an acute rejection episode requiring reinstitution of immunosuppression |
GSM562636 | L-NonTol | Liver recipients in whom drug weaning was attempted but this led to an acute rejection episode requiring reinstitution of immunosuppression |
GSM562636 | L-NonTol | Liver recipients in whom drug weaning was attempted but this led to an acute rejection episode requiring reinstitution of immunosuppression |
GSM562636 | L-NonTol | Liver recipients in whom drug weaning was attempted but this led to an acute rejection episode requiring reinstitution of immunosuppression |
GSM562636 | L-NonTol | Liver recipients in whom drug weaning was attempted but this led to an acute rejection episode requiring reinstitution of immunosuppression |
GSM562636 | L-NonTol | Liver recipients in whom drug weaning was attempted but this led to an acute rejection episode requiring reinstitution of immunosuppression |
GSM562636 | L-NonTol | Liver recipients in whom drug weaning was attempted but this led to an acute rejection episode requiring reinstitution of immunosuppression |
GSM562636 | L-NonTol | Liver recipients in whom drug weaning was attempted but this led to an acute rejection episode requiring reinstitution of immunosuppression |
GSM562636 | L-NonTol | Liver recipients in whom drug weaning was attempted but this led to an acute rejection episode requiring reinstitution of immunosuppression |
GSM562636 | L-NonTol | Liver recipients in whom drug weaning was attempted but this led to an acute rejection episode requiring reinstitution of immunosuppression |
GSM562636 | L-NonTol | Liver recipients in whom drug weaning was attempted but this led to an acute rejection episode requiring reinstitution of immunosuppression |
GSM562636 | L-NonTol | Liver recipients in whom drug weaning was attempted but this led to an acute rejection episode requiring reinstitution of immunosuppression |
GSM562648 | K-Sta | kidney recipients with stable graft function under maintenance immunosuppression |
GSM562648 | K-Sta | kidney recipients with stable graft function under maintenance immunosuppression |
GSM562648 | K-Sta | kidney recipients with stable graft function under maintenance immunosuppression |
GSM562648 | K-Sta | kidney recipients with stable graft function under maintenance immunosuppression |
GSM562648 | K-Sta | kidney recipients with stable graft function under maintenance immunosuppression |
GSM562648 | K-Sta | kidney recipients with stable graft function under maintenance immunosuppression |
GSM562648 | K-Sta | kidney recipients with stable graft function under maintenance immunosuppression |
GSM562648 | K-Sta | kidney recipients with stable graft function under maintenance immunosuppression |
GSM562648 | K-Sta | kidney recipients with stable graft function under maintenance immunosuppression |
GSM562648 | K-Sta | kidney recipients with stable graft function under maintenance immunosuppression |
GSM562648 | K-Sta | kidney recipients with stable graft function under maintenance immunosuppression |
GSM562648 | K-Sta | kidney recipients with stable graft function under maintenance immunosuppression |
GSM562660 | K-CR | kidney recipients under standard immunosuppression with deteriorating kidney graft function |
GSM562660 | K-CR | kidney recipients under standard immunosuppression with deteriorating kidney graft function |
GSM562660 | K-CR | kidney recipients under standard immunosuppression with deteriorating kidney graft function |
GSM562660 | K-CR | kidney recipients under standard immunosuppression with deteriorating kidney graft function |
GSM562660 | K-CR | kidney recipients under standard immunosuppression with deteriorating kidney graft function |
GSM562660 | K-CR | kidney recipients under standard immunosuppression with deteriorating kidney graft function |
GSM562660 | K-CR | kidney recipients under standard immunosuppression with deteriorating kidney graft function |
GSM562660 | K-CR | kidney recipients under standard immunosuppression with deteriorating kidney graft function |
GSM562660 | K-CR | kidney recipients under standard immunosuppression with deteriorating kidney graft function |
GSM562660 | K-CR | kidney recipients under standard immunosuppression with deteriorating kidney graft function |
GSM562660 | K-CR | kidney recipients under standard immunosuppression with deteriorating kidney graft function |
GSM562660 | K-CR | kidney recipients under standard immunosuppression with deteriorating kidney graft function |
GSM562672 | HV | healthy volunteers |
GSM562672 | HV | healthy volunteers |
GSM562672 | HV | healthy volunteers |
GSM562672 | HV | healthy volunteers |
GSM562672 | HV | healthy volunteers |
GSM562672 | HV | healthy volunteers |
GSM562672 | HV | healthy volunteers |
GSM562672 | HV | healthy volunteers |
GSM562672 | HV | healthy volunteers |
GSM562672 | HV | healthy volunteers |
GSM562672 | HV | healthy volunteers |
GSM562672 | HV | healthy volunteers |